ADARx Pharmaceuticals, Inc. ADRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.27% | -5.04% | 0.00% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.76% | -3.56% | 0.00% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.80% | -5.00% | 0.00% | -- | -- |
|
|
|||||
| Total Current Assets | -5.80% | -5.00% | 0.00% | -- | -- |
| Net Property, Plant & Equipment | -5.29% | -3.91% | 0.00% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 69.87% | 1.36% | 0.00% | -- | -- |
| Total Assets | -5.43% | -4.94% | 0.00% | -- | -- |
|
|
|||||
| Total Accounts Payable | -28.23% | 15.91% | 0.00% | -- | -- |
| Total Accrued Expenses | 34.30% | -0.28% | 0.00% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.06% | -0.06% | 0.00% | -- | -- |
| Total Finance Division Other Current Liabilities | 26.76% | -9.91% | 0.00% | -- | -- |
| Total Other Current Liabilities | 26.76% | -9.91% | 0.00% | -- | -- |
| Total Current Liabilities | 14.31% | -2.39% | 0.00% | -- | -- |
|
|
|||||
| Total Current Liabilities | 14.31% | -2.39% | 0.00% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.66% | -6.82% | 0.00% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.50% | -0.15% | 0.00% | -- | -- |
| Total Liabilities | -0.26% | -0.46% | 0.00% | -- | -- |
|
|
|||||
| Common Stock & APIC | 8.82% | 5.09% | 0.00% | -- | -- |
| Retained Earnings | -10.58% | -10.27% | 0.00% | -- | -- |
| Treasury Stock & Other | -355.88% | -84.35% | 0.00% | -- | -- |
| Total Common Equity | -11.22% | -11.61% | 0.00% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -- | -- |
|
|
|||||
| Total Common Equity | -11.22% | -11.61% | 0.00% | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -19.20% | -15.11% | 0.00% | -- | -- |
|
|
|||||